Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 03 dec 2018 - 07:16
- Statutory name argenx SE
- Title argenx enters exclusive global collaboration and license agreement with Cilag GmbH International, an affiliate of Janssen, for cusatuzumab (ARGX-110)
Date last update: 20 January 2019